Steroid-refractory aGvHD Subsequent to Allogeneic Hematopoietic Cell Transplantation

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Steroid-refractory aGvHD Subsequent to Allogeneic Hematopoietic Cell Transplantation trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

WithdrawnPhase 2

NCT02694770

A Study Evaluating the Efficacy and Safety of Neihulizumab vs "Conventional Treatment" to Treat Sr-aGvHD

This study is to assess the efficacy of Neihulizumab versus "conventional therapy" and to evaluate safety, pharmacokinetics and immunogenicity in treating stero…

United States0Started 2016-07

Treatment: Neihulizumab Treatment, Conventional Treatment